Current and future prospects in treating multiple myeloma
21 Jul 2017
Current and future prospects in treating multiple myeloma
Celebrating a 10 year partnership: ecancer and the IEO
Measuring Success in Indolent Disease: Discuss, Debate, Decide
What’s important to patients in a non-curative setting?
What to do when standard treatment fails?
How do we measure treatment success?
The challenge of approving add-on therapies for patients with metastatic cancer
Biomarker research in breast cancer
New biomarkers for response to immunotherapy
Current and future immune approaches in precision medicine
Precision medicine enabled histology agnostic development of immunotherapeutics
Patient-specific peptide vaccines